BusinessSucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270By Nasdaq OMXJun 13, 2017, 8:30 PM UTC
BusinessNew Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1By Nasdaq OMXApr 18, 2017, 10:30 AM UTC
